Clinical Trial Update: Study on Autologous Osteoblastic Cells Implantation to Early Stage Osteonecrosis of the Femoral Head [Phase 3]

View source ↗

Summary

Phase 3 trial on autologous osteoblastic cell implantation for early-stage osteonecrosis of the femoral head has been terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteonecrosis of the Femoral Head

Drugs mentioned

• Autologous osteoblastic cells implantation (Bone Therapeutics S.A. program)

Snippet

Sponsor: Bone Therapeutics S.A | Conditions: Osteonecrosis of the Femoral Head | Phase 3 | Status: TERMINATED | Results posted: 2022-06-24